BioWorld MedTech

Oct. 16, 2012

Agreements/contracts: BD Diag, Lab21 in accord to develop cancer detection assays

It only took one successful assay developed by BD Diagnostics (Circle Sparks, Maryland) and Lab21 (Cambridge, UK), for both firms to realize they had something special when it comes to working together to get new products to market. Read More

Washington roundup: Anthem: MP-RAGE MRI a no-go for all indications

Report from Europe: Critical Diagnostics signs four partners for Presage

ICU Medical launches NanoClave connector

Deals roundup: The Gores Group to acquire Therakos from Ortho-Clinical

Grants roundup: Cardinal Health invites providers to apply for patient safety grants

Patent watch: nContact reaches milestone with new coverage of devices

Med-Tech Notes

Product Briefs

People in the News

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 11, 2025.

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...

News in brief

BioWorld Asia

BioWorld Asia briefs for Feb. 10, 2026

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...